MECOCCI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 17.345
EU - Europa 14.070
AS - Asia 13.101
SA - Sud America 2.419
Continente sconosciuto - Info sul continente non disponibili 1.457
AF - Africa 334
OC - Oceania 18
Totale 48.744
Nazione #
US - Stati Uniti d'America 16.776
SG - Singapore 6.147
IT - Italia 3.855
BR - Brasile 1.893
IE - Irlanda 1.812
RU - Federazione Russa 1.701
HK - Hong Kong 1.675
UA - Ucraina 1.551
CN - Cina 1.539
VN - Vietnam 1.411
SE - Svezia 1.260
FR - Francia 974
DE - Germania 871
FI - Finlandia 606
KR - Corea 515
GB - Regno Unito 434
BD - Bangladesh 370
IN - India 306
CA - Canada 271
AT - Austria 221
TR - Turchia 199
AR - Argentina 197
NL - Olanda 157
MX - Messico 155
IQ - Iraq 140
PL - Polonia 139
CH - Svizzera 126
JP - Giappone 102
PK - Pakistan 101
ZA - Sudafrica 90
ES - Italia 88
UZ - Uzbekistan 79
CO - Colombia 71
EC - Ecuador 68
VE - Venezuela 66
ID - Indonesia 65
PH - Filippine 60
SA - Arabia Saudita 58
BE - Belgio 53
MY - Malesia 50
MA - Marocco 43
CL - Cile 38
CZ - Repubblica Ceca 37
JO - Giordania 37
TN - Tunisia 32
KE - Kenya 30
PY - Paraguay 30
RO - Romania 30
JM - Giamaica 28
GR - Grecia 27
LT - Lituania 27
AE - Emirati Arabi Uniti 25
CR - Costa Rica 25
DZ - Algeria 25
IR - Iran 24
LB - Libano 24
EG - Egitto 23
NP - Nepal 23
ET - Etiopia 19
IL - Israele 19
PE - Perù 18
AL - Albania 17
BO - Bolivia 17
EU - Europa 17
UY - Uruguay 17
HN - Honduras 16
DO - Repubblica Dominicana 15
TH - Thailandia 15
BG - Bulgaria 13
KZ - Kazakistan 13
PS - Palestinian Territory 13
AU - Australia 12
OM - Oman 12
SV - El Salvador 11
AZ - Azerbaigian 9
BY - Bielorussia 8
PA - Panama 8
SC - Seychelles 8
SY - Repubblica araba siriana 8
TW - Taiwan 8
XK - ???statistics.table.value.countryCode.XK??? 8
AO - Angola 7
GE - Georgia 7
HU - Ungheria 7
KG - Kirghizistan 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
MD - Moldavia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BB - Barbados 5
BH - Bahrain 5
GT - Guatemala 5
LV - Lettonia 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
TZ - Tanzania 5
Totale 47.191
Città #
Singapore 4.348
Chandler 1.967
Dublin 1.810
Hong Kong 1.667
San Jose 1.642
Ashburn 1.075
San Mateo 896
Jacksonville 843
Boardman 785
Dong Ket 722
Santa Clara 710
Moscow 595
Altamura 523
Seoul 496
Lauterbourg 468
Medford 467
Princeton 462
Perugia 417
Lawrence 396
Beijing 369
Wilmington 345
Los Angeles 344
Andover 266
Munich 265
New York 247
Ho Chi Minh City 232
Ann Arbor 230
Piscataway 222
Rome 204
Milan 198
The Dalles 190
São Paulo 175
Hanoi 172
Helsinki 143
Des Moines 133
Vienna 128
Frankfurt am Main 126
Saint Petersburg 121
Dallas 116
Nuremberg 112
Norwalk 101
Turku 99
Tokyo 95
Redmond 94
Montreal 91
Houston 84
Falls Church 83
Orem 79
Brooklyn 76
Izmir 76
Chicago 74
San Paolo di Civitate 70
Naples 67
Warsaw 67
Toronto 66
Chennai 64
Baghdad 61
Bologna 60
Phoenix 60
Woodbridge 60
London 59
Rio de Janeiro 57
Buffalo 56
Denver 54
Atlanta 52
Palermo 52
Amsterdam 51
Mexico City 49
Boston 47
San Francisco 47
Shanghai 47
Brussels 46
Johannesburg 45
Redwood City 45
Florence 44
Tashkent 43
Council Bluffs 41
Poplar 40
Belo Horizonte 39
Curitiba 39
Genoa 39
Lappeenranta 39
Stockholm 38
Manchester 37
Padova 37
Bari 36
Brasília 36
Haiphong 35
Hefei 35
Dearborn 34
Amman 32
Dhaka 29
Falkenstein 29
Istanbul 29
Terni 29
Columbus 28
Lahore 28
Prato 27
Seattle 26
Turin 26
Totale 27.756
Nome #
Validazione della versione italiana della Geriatric Depression Scale a 5 item in tre differenti setting assistenziali 1.790
I disturbi comportamentali “clinicamente rilevanti” nella demenza vascolare, nella demenza a corpi di Lewy e nella demenza di Alzheimer: studio su 921 pazienti anziani. 452
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 285
Musicalmente: sviluppo di un paradigma per la valutazione dell’efficacia della musicoterapia nel trattamento della demenza 246
Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. 199
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 197
Paziente anziano, paziente geriatrico e medicina della complessità. Fondamenti di Gerontologia e Geriatria (III edizione) 185
Fracture prevention service to bridge the osteoporosis care gap 173
Antiossidanti plasmatici e longevità: studio su centenari sani 165
The brain of the elderly between normality and pathology: Techniques and technologies for the evaluation 160
Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. 159
Axonal injury within language network in primary progressive aphasia 158
Antioxidants for the treatment of mild cognitive impairment. (Review) 156
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. 153
Platelet MAO-B activity and vitamin B12 in old age dementias. 149
Dementia, depression and parkinsonism: A frequent association in the elderly. 149
Validation study of the Italian Addenbrooke’s Cognitive Examination Revised in a young-old and old-old population 149
Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. 148
H-1-MR spectroscopy differentiates mild cognitive impairment from normal brain aging 147
Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study 145
Normative data for the ACE-R in an Italian population sample. 145
Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia 143
A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks. 141
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics. 140
Prevalence of Aging-Associated Cognitive Decline - AACD in an Italian elderly population: results from the cross sectional phase of the Italian PRoject on the Epidemiology of Alzheimer's disease (I.PR.E.A.). 139
The orthogeriatric management: an inseparable duo to foster appropriate care 139
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis 136
Antibiotic use and associated factors in a large sample of hospitalised older people 136
Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature 136
The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults 136
Altered mitochondrial membrane fluidity in AD brain. 135
Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation 134
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle 134
Influenza della comorbilità e dello stato cognitivo sulle attività strumentali della vita quotidiana nei soggetti con Mild Cognitive Impairment Amnesico (aMCI): risultati del Progetto ReGAl. 134
Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. 133
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study 133
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 132
Alterazioni biochimiche nel cervello di soggetti con ipertensione cronica e in pazienti con demenza di Alzheimer in fase precoce valutate mediante risonanza magnetica spettroscopica 132
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy. 132
Common brain disorders are associated with heritable patterns of apparent aging of the brain 131
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 130
Blood pressure and functional aspects of the aging brain. 130
Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project 130
Antioxidant profile and early outcome in stroke patients. 129
The effects of aging and endurance exercise on cardiovascular performance in healthy elderly: a review of the literature. 129
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort 128
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease 128
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 127
Oxidative stress and dementia: new perspectives in AD pathogenesis. 127
La risonanza magnetica spettroscopica differenzia il Mild Cognitive Impairment dal normale invecchiamento cerebrale 127
Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons 127
Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project 127
Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study 126
Rapidly progressive aphasic dementia with motor neuron disease: A distinctive clinical entity 125
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 125
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease 125
Attività dell'Aconitasi Mitocondriale nella demenza di Alzheimer e nel Mild cognitive impairment 125
Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease. 125
Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. 125
miRNAs and Alzheimer's Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population 124
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 124
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 124
Effects of weekly supplementation of cholecalciferol and calcifediol among the oldest-old people: Findings from a randomized pragmatic clinical trial 124
Validation of the five-item geriatric depression scale in elderly subjects in three different settings. 123
Metabolic Score for Insulin Resistance (METS-IR) and Circulating Cytokines in Older Persons: The Role of Gender and Body Mass Index 122
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 122
Elevati livelli plasmatici delle forme di vitamina E e riduzione del rischio di malattia di Alzheimer in età avanzata 122
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment 120
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 120
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 120
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 119
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts 119
Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer’s disease 119
Antioxidant agents in Alzheimer’s disease 119
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer disease and mild cognitive impairment 119
Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status : Results from the Zincage Project. 119
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 118
Predicting progression of Alzheimer's disease using ordinal regression 118
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 118
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 118
Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic MCI: Results from the ReGAl project. 117
An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients 117
Gli effetti dell’anemia e dell’emotrasfusione sugli indicatori clinici nel paziente anziano con frattura di femore. 117
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey 116
Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. 116
Il ruolo dei fattori di rischio vascolare nei sottotipi di mild cognitive impairment. Risultati del progetto ReGAl 116
Automatically computed rating scales from MRI for patients with cognitive disorders 116
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 116
Deterioramento cognitivo e sviluppo di sindromi geriatriche durante il ricovero ospedaliero: risultati dello studio GIFA 115
The “Artwork Effect” paradigm: A model for planning and assessing cognitive stimulation for people with dementia through museum visits 115
Beta-carotene, telomerase activity and Alzheimer’s disease in old age subjects 115
cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders 115
Music Therapy Effects in People with Dementia 114
Hypovitaminosis d: A disease marker in hospitalized very old persons at risk of malnutrition 114
Detecting frontotemporal dementia syndromes using MRI biomarkers 114
Superficial siderosis of the central nervous system: a 70-year-old man with ataxia, depression and visual deficits 114
Common genetic variants influence human subcortical brain structures. 113
Is multi-infarct dementia representative of vascular dementias? A retrospective study 113
Effects of vitamin A administration on serum thyrotropin concentrations in healthy human subjects 113
Nutraceuticals in cognitive impairment and Alzheimer's disease 113
Totale 15.331
Categoria #
all - tutte 224.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.007 0 0 128 245 137 70 71 1.126 120 121 447 542
2022/20236.909 500 1.374 76 526 534 694 89 341 2.427 55 204 89
2023/20242.969 204 331 156 97 29 26 476 130 424 122 499 475
2024/20257.495 186 741 328 179 777 367 419 599 1.670 545 1.024 660
2025/202617.511 1.300 1.305 983 2.176 2.070 1.515 3.060 1.101 1.870 1.209 558 364
2026/20271.378 395 905 78 0 0 0 0 0 0 0 0 0
Totale 48.744